These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29578611)

  • 1. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
    Essali A; Soares-Weiser K; Bergman H; Adams CE
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    Bergman H; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000204. PubMed ID: 29341071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Essali A; Deirawan H; Soares-Weiser K; Adams CE
    Cochrane Database Syst Rev; 2011 Nov; (11):CD000206. PubMed ID: 22071797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2004; (1):CD000206. PubMed ID: 14973950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepines for antipsychotic-induced tardive dyskinesia.
    Bergman H; Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000205. PubMed ID: 29352477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2001; (1):CD000206. PubMed ID: 11279683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Bergman H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000203. PubMed ID: 29663328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000209. PubMed ID: 29341067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000206. PubMed ID: 10796323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic medication for antipsychotic-induced tardive dyskinesia.
    Tammenmaa-Aho I; Asher R; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000207. PubMed ID: 29553158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J; Ogawa Y; Shinohara K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000208. PubMed ID: 29552749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
    Bergman H; Rathbone J; Agarwal V; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD000459. PubMed ID: 29409162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jul; (3):CD000205. PubMed ID: 16855954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
    Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; McGrath J
    Cochrane Database Syst Rev; 2011 Feb; (2):CD000209. PubMed ID: 21328246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser KV; Joy C
    Cochrane Database Syst Rev; 2003; (2):CD000208. PubMed ID: 12804390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.